Earnings

Harmony Biosciences Q3 EPS $0.81 Misses $1.10 Estimate, Sales $268.917M Miss $273.078M Estimate

Nov 4, 2026 · 07:33 AM ET· updated 2h ago

Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.81 per share which missed the analyst consensus estimate of $1.10 by 26.36 percent. This is a 25 percent decrease over earnings of $1.08 per share from

Why It Matters

Harmony Biosciences made less money than experts thought it would. When a company earns less than expected, watch to see if the problem is temporary or if the business is slowing down.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

HRMY33.58

-3.44 (-9.29%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.